Renewed interest in the progesterone receptor in breast cancer.
作者信息
Lim Elgene, Palmieri Carlo, Tilley Wayne D
机构信息
Garvan Institute of Medical Research and St Vincent's Hospital, University of New South Wales, NSW, Sydney, Australia.
Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
出版信息
Br J Cancer. 2016 Oct 11;115(8):909-911. doi: 10.1038/bjc.2016.303. Epub 2016 Sep 22.
Abstract
摘要
相似文献
1
Renewed interest in the progesterone receptor in breast cancer.对乳腺癌中孕激素受体的兴趣再度兴起。
Br J Cancer. 2016 Oct 11;115(8):909-911. doi: 10.1038/bjc.2016.303. Epub 2016 Sep 22.
2
Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer.人乳腺癌中的胞质和核雌激素受体（占据和未占据位点）及孕激素受体
Breast Cancer Res Treat. 1985;5(2):165-9. doi: 10.1007/BF01805990.
3
[Progesterone receptors in breast cancer].
Vopr Onkol. 1987;33(9):35-8.
4
Progesterone receptors and human breast cancer.孕酮受体与人类乳腺癌
Breast Cancer Res Treat. 1983;3(2):157-63. doi: 10.1007/BF01803558.
5
Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.用于定量检测人乳腺癌中雌激素和孕激素受体免疫反应性的半自动成像系统。
J Microsc. 2007 Jun;226(Pt 3):244-55. doi: 10.1111/j.1365-2818.2007.01772.x.
6
Status of estrogen and progesterone receptors in various phases of the menstrual cycle in breast cancer.乳腺癌患者月经周期各阶段雌激素和孕激素受体的状态
Arch Iran Med. 2006 Jul;9(3):250-3.
7
Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.探索雌激素和孕激素信号传导的空间维度：检测乳腺癌旁正常乳腺小叶上皮细胞中的核标记。
Diagn Pathol. 2014;9 Suppl 1(Suppl 1):S11. doi: 10.1186/1746-1596-9-S1-S11. Epub 2014 Dec 19.
8
9
Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.雌激素和孕激素受体在原发性可手术乳腺癌中的预后意义
Jpn J Clin Oncol. 1990 Sep;20(3):271-80.
10
Estrogen and progesterone receptors in breast cancer.乳腺癌中的雌激素和孕激素受体
Future Oncol. 2014 Nov;10(14):2293-301. doi: 10.2217/fon.14.110.
引用本文的文献
1
Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring.液体活检的双重生物标志物策略：整合循环肿瘤细胞和循环肿瘤DNA以加强肿瘤监测
Biosensors (Basel). 2025 Jan 28;15(2):74. doi: 10.3390/bios15020074.
2
Ancient and modern mechanisms compete in progesterone receptor activation.古今机制在孕激素受体激活方面相互竞争。
RSC Chem Biol. 2024 Apr 15;5(6):518-529. doi: 10.1039/d4cb00002a. eCollection 2024 Jun 5.
3
Deep learning infers clinically relevant protein levels and drug response in breast cancer from unannotated pathology images.深度学习从未标注的病理图像中推断出乳腺癌中临床相关的蛋白质水平和药物反应。
NPJ Breast Cancer. 2024 Feb 27;10(1):18. doi: 10.1038/s41523-024-00620-y.
4
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer.雌激素/HER2受体在乳腺癌中的相互作用：联合疗法改善激素受体阳性/HER2阳性乳腺癌患者的预后
NPJ Breast Cancer. 2023 May 31;9(1):45. doi: 10.1038/s41523-023-00533-2.
5
Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer.非甾体抗炎药与生物标志物：结直肠癌的一种新范式
Front Med (Lausanne). 2023 Mar 6;10:1130710. doi: 10.3389/fmed.2023.1130710. eCollection 2023.
6
FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer.FGF7/FGFR2-JunB 信号传导拮抗孕激素在乳腺腔肿瘤中的作用。
Mol Oncol. 2022 Aug;16(15):2823-2842. doi: 10.1002/1878-0261.13274. Epub 2022 Jul 4.
7
New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling.孕酮受体（PR）亚型功能及孕酮信号传导的新见解。
Am J Cancer Res. 2021 Nov 15;11(11):5214-5232. eCollection 2021.
8
The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease.HPSE 基因绝缘子-一种影响肝素酶表达、干细胞动员和急性移植物抗宿主病风险的新型调节元件。
Cells. 2021 Sep 23;10(10):2523. doi: 10.3390/cells10102523.
9
Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer.姜黄素：激素非依赖性乳腺癌关键分子信号通路的调节剂
Cancers (Basel). 2021 Jul 8;13(14):3427. doi: 10.3390/cancers13143427.
10
Synthesis, Characterization, and Preliminary In Vitro Cytotoxic Evaluation of a Series of 2-Substituted Benzo [] [1,3] Azoles.一系列 2-取代苯并 [1,3] 恶唑的合成、表征及初步体外细胞毒性评价。
Molecules. 2021 May 8;26(9):2780. doi: 10.3390/molecules26092780.
本文引用的文献
1
The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone.乳腺癌中的联合内分泌受体，一种对传统激素受体解读的新方法，且比单独的雌激素受体（ER）和孕激素受体（PR）更能区分预后。
Br J Cancer. 2016 Oct 11;115(8):967-973. doi: 10.1038/bjc.2016.206. Epub 2016 Sep 22.
2
Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review.原发性与转移性乳腺肿瘤之间雌激素、孕激素及HER2/neu受体的不一致性——综述
Cancer Metastasis Rev. 2016 Sep;35(3):427-37. doi: 10.1007/s10555-016-9631-3.
3
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.芳香酶抑制剂与他莫昔芬治疗早期乳腺癌：随机试验的患者水平荟萃分析。
Lancet. 2015 Oct 3;386(10001):1341-1352. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.
4
Progesterone receptor modulates ERα action in breast cancer.孕激素受体调节乳腺癌中雌激素受体α的作用。
Nature. 2015 Jul 16;523(7560):313-7. doi: 10.1038/nature14583. Epub 2015 Jul 8.
5
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.帕博西尼治疗激素受体阳性晚期乳腺癌。
N Engl J Med. 2015 Jul 16;373(3):209-19. doi: 10.1056/NEJMoa1505270. Epub 2015 Jun 1.
6
Multigene prognostic tests in breast cancer: past, present, future.乳腺癌中的多基因预后检测：过去、现在与未来。
Breast Cancer Res. 2015 Jan 27;17(1):11. doi: 10.1186/s13058-015-0514-2.
7
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.孕激素受体表达是早期乳腺癌的一个独立预后变量：一项基于人群的研究。
Br J Cancer. 2014 Feb 4;110(3):565-72. doi: 10.1038/bjc.2013.756. Epub 2013 Dec 3.
8
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.雌激素受体阴性/孕激素受体阳性乳腺癌并非一种可重复的亚型。
Breast Cancer Res. 2013;15(4):R68. doi: 10.1186/bcr3462.
9
Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss.基于雌激素受体信号的内在乳腺癌亚型-孕激素受体缺失的预后相关性。
Mod Pathol. 2013 Sep;26(9):1161-71. doi: 10.1038/modpathol.2013.60. Epub 2013 Apr 5.
10
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.2000 个乳腺肿瘤的基因组和转录组结构揭示了新的亚群。
Nature. 2012 Apr 18;486(7403):346-52. doi: 10.1038/nature10983.
Zotero 插件